JABET Explore more articles

Table 1. Effect of C. maxima aqueous seed  extract on levels of fasting blood glucose on alloxan-induced diabetes in rats.

 

 

 

Blood glucose levels (mmol/L)

 

 

Treatment

Baseline

0 h

2 h

4 h

6 h

24 h

Day 7

Day 14

Day 21

Day 28

Non-diabetic

5.12±0.20a

4.88±0.34b

4.94±0.27c

4.68±0.32d

5.04±0.28e

5.08±0.18d

5.06±0.29e

5.28±0.19d

5.20±0.19e

5.04±0.22d

Diabetic

5.20±0.21a

28.90±0.58a

29.16±0.74a

29.78±0.86a

29.48±0.43a

30.58±0.68a

30.08±0.71a

31.54±1.97a

29.42±0.75a

29.62±0.50a

Glibenclamide

5.20±0.23a

30.46±0.84a

25.14±0.35b

22.04±0.56c

19.92±0.34d

19.78±0.38c

13.28±0.54d

13.06±0.55c

12.16±0.44d

11.89±0.30c

200 mg/kg bw AqE

5.32±0.28a

29.64±0.36a

28.80±0.44a

27.94±0.38a

26.56±0.33b

25.00±0.26b

21.84±0.37b

19.06±0.35b

18.44±0.44b

15.14±0.34b

400 mg/kg bw AqE

5.24±0.25a

29.82±0.31a

27.78±0.23a

25.10±0.41b

23.12±0.28c

19.74±0.35c

17.22±0.28c

15.30±0.33bc

14.96±0.20c

13.90±0.21b

Using one-way ANOVA and Tukey's multiple comparisons, the means with mean±standard error that do not share a lowercase superscript letter along the column vary significantly (p<0.05). Non-diabetic = normal control; diabetic = alloxan treated-negative control; glibenclamide = reference drug treated to diabetic rats; AqE = aqueous extract treated to diabetic rats.